Skip to main content
SpringerLink
Log in

Cardiac MRI in Diagnosis and Management

  • Chapter
  • First Online:
Hypertrophic Cardiomyopathy

  • 1962 Accesses

Abstract

Cardiac magnetic resonance imaging (CMR) is an essential tool in the diagnosis, risk stratification and treatment of patients with hypertrophic cardiomyopathy (HCM). CMR works by manipulating protons found in myocytes and contrast agents such as Gadolinium, using magnetic pull to create and then detect energy differences and thus obtain images. CMR is ideal for detecting the location and extent of hypertrophy, presence or absence of membranes, the distribution of fibrosis and the anatomy and physiology of the mitral valve, all of which are crucial for diagnosis of HCM, which can be missed on standard echocardiography. This is especially true for hard to see areas of the heart such as the apical area as well as atypical presentations such as focal segmental hypertrophy or mass-like HCM. Additionally, extremely accurate assessments of the left ventricular volumes, mass and function are prognostic as well as diagnostic. Magnetic resonance tagging and delayed-enhancement with Gadolinium allow for strain and perfusion analysis, further increasing the utility of CMR to detect regional function and cardiac microvascular ischemia, of which HCM patients are particularly susceptible. Delayed enhancement distribution and extent may also impact risk stratification for sudden cardiac death. Limitations of CMR include assessment of the left ventricular outflow tract gradient and highly mobile structures on the mitral valve, although newer protocols and improved technology may be able to compensate for these deficits in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bruder O, Schneider S, Nothnage D, Dill T, Hombach V, Schulz-Menger J, Nagel E, Lombardi M, van Rossum AC, Wagner A, Schwitter J, Senges J, Sabin GV, Sechtem U, Mahroldt H. EuroCMR [European Cardiovascular Magnetic Resonance] registry. J Am Coll Cardiol. 2009;54(15):1457–66.

    Article  PubMed  Google Scholar 

  2. Cerqueira MD, Weissman NJ, Dilsizian V, Joacobs AK, Kaul S, Laskey WK, Pennell J, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539–42.

    Article  PubMed  Google Scholar 

  3. Plein S, Bloomer TN, Ridgway JP, Jones TR, Bainbridge GJ, Sivananthan MU. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging. 2001;14:230–6.

    Article  CAS  PubMed  Google Scholar 

  4. Miller S, Simonetti OP, Carr J, Kramer U, Finn JP. MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on the left ventricular functional parameters. Radiology. 2002;223:263–9.

    Article  PubMed  Google Scholar 

  5. Roussakis A, Baras P, Seimenis I, Andreou J, Danias PG. Relationship of number of phases per cardiac cycle and accuracy of measurement of left ventricular volumes, ejection fraction and mass. J Cardiovasc Magn Reson. 2004;6:837–44.

    Article  PubMed  Google Scholar 

  6. Nagel E, Schneider U, Schalla S. Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson. 2000;2:7–14.

    Article  CAS  PubMed  Google Scholar 

  7. Jahnke C, Nagel E, Gebker R. Four-dimensional single breathhold magnetic resonance imaging using kt-BLAST enables reliable assessment of left- and right-ventricular volumes and mass. J Magn Reson Imaging. 2007;25:737–42.

    Article  PubMed  Google Scholar 

  8. Gerber BL, Raman SV, Nayak K. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory and current state of the art. J Cardiovasc Magn Reson. 2008;10:18–36.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Jerosch-Herold M, Seethamraju RT, Swingen CM, Wilke NM, Stillman AE. Analysis of myocardial perfusion MRI. J Magn Reson Imaging. 2004;19:758–70.

    Article  PubMed  Google Scholar 

  10. Romero J, Kahan J, Kelesidis I, Makani H, Wever-Pinzon O, Medina H, Garcia MJ. CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials. Eur Heart J Cardiovasc Imaging. 2013;14(11):1080–91.

    Article  PubMed  Google Scholar 

  11. Chen MM, Coakley FV, Kaimal A, Laros Jr RK. Guidelines for computed tomography and magnetic resonance imaging use in pregnancy and lactation. Obstet Gynecol. 2008;112(2):333–40.

    Article  PubMed  Google Scholar 

  12. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley Jr WG, Froelich JW. ACR guidance document for safe MR practices: 2007. AJR Am J Roentegnol. 2007;188:1447–74.

    Article  Google Scholar 

  13. Heinrichs WL, Fong P, Flannery M, Heinrichs SC, Crooks LE, Spindle A. Midgestational exposure of pregnant BALB/c mice to magnetic resonance imaging conditions. Magn Reson Imaging. 1988;6:305–13.

    Article  CAS  PubMed  Google Scholar 

  14. Levine GN, Gomes AS, Arai AE. Safety of magnetic resonance imaging in patients with cardiovascular devices: an american Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic REsonance. Circulation. 2007;116:2878–91.

    Article  PubMed  Google Scholar 

  15. Kanal E, Barkovich AJ, Bell C. ACR guidance document for safe MR practices. AJR Am J Roentgenol. 2007;188:1447–74.

    Article  PubMed  Google Scholar 

  16. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol. 2005;28(4):326–8.

    Article  PubMed  Google Scholar 

  17. Francis JM, Pennel DJ. Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. J Cardiovasc Magn Reson. 2000;2:139–41.

    Article  CAS  PubMed  Google Scholar 

  18. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:2.

    Google Scholar 

  19. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007;115:6.

    Article  Google Scholar 

  20. Eriksson MJ, Sonnenberg B, Woo A. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39:638–45.

    Article  PubMed  Google Scholar 

  21. Olivotto L, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F, Salton CJ, Udelson JE, Manning WJ, Maron BJ. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52(7):559–66.

    Article  PubMed  Google Scholar 

  22. Sakuma H. Late gadolinium enhancement and prognosis of hypertrophic cardiomyopathy. Circ J. 2014;78(4):823–34.

    Article  Google Scholar 

  23. Rickers C, Wilke NM, Jerosch-Herold M. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855–61.

    Article  PubMed  Google Scholar 

  24. Elliot P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–91.

    Article  Google Scholar 

  25. Geske JB, Sorajja P, Ommen SR, Nishimura RA. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011;4(6):704–9.

    Article  PubMed  Google Scholar 

  26. Wigle ED. Cardiomyopathy: the diagnosis of hypertrophic cardiomyopathy. Heart. 2001;86:709–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Noureidin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14(17):1–13.

    Google Scholar 

  28. Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet. 2013;6(3):230–7.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol. 1999;72:258–64.

    Article  CAS  PubMed  Google Scholar 

  30. Sperling RT, Parker JA, Manning WJ, Danias PG. Apical hypertrophic cardiomyopathy: clinical, electrocardiographic, scintiagraphic, echocardiographic and magnetic resonance imaging findings of a case. J Cardiovasc Magn Reson. 2002;4:291–5.

    Article  PubMed  Google Scholar 

  31. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004;90:645–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Refaat M. Prognosis of apical hypertrophic cardiomyopathy. JAMA. 2007;298(17):2006.

    Article  CAS  PubMed  Google Scholar 

  33. Abinader EG. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(4):837–8.

    Article  PubMed  Google Scholar 

  34. Maron MS, Maron BJ, Harrigan C. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220–8.

    Article  PubMed  Google Scholar 

  35. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44(11):2125–32.

    Article  PubMed  Google Scholar 

  36. Bergey PD, Axel L. Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. AJR Am J Roentgenol. 2000;184:242–4.

    Article  Google Scholar 

  37. Harrigan CJ, Appelbaum E, Maron BJ. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2008;101:668–73.

    Article  PubMed  Google Scholar 

  38. Kwon DH, Setser RM, Thamilarasan M. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2008;94:1295–301.

    Article  CAS  PubMed  Google Scholar 

  39. Desai MY, Ommen SR, McKenna WJ, Lever MH, Elliott PM. Imaging phenotype versus genotype in hypertrophic cardiomyopathy. Circulation. 2011;4:156–68.

    PubMed  Google Scholar 

  40. Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011;123:40–7.

    Article  Google Scholar 

  41. Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992;85(5):1651–60.

    Article  CAS  PubMed  Google Scholar 

  42. Maron BJ, Nishimura RA, Danielson GK. Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. Circulation. 1998;98(23):2505–8.

    Article  CAS  PubMed  Google Scholar 

  43. Sherrid MV, Gunsburg EZ, Moldenhauer S, Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2000;22(3):816–25.

    Article  Google Scholar 

  44. Kellman P, Arai AE. Imaging sequences for first pass perfusion – a review. J Cardiovasc Magn Reson. 2007;9:525–37.

    Article  PubMed  Google Scholar 

  45. Maron MS, Olivotto I, Betocchi S. Effect of the left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303.

    Article  PubMed  Google Scholar 

  46. Hope MD, Meadows AK, Hope TA. Clinical evaluation of aortic coarctation with 4D flow MR imaging. J Magn Reson Imaging. 2010;31:711–8.

    Article  PubMed  Google Scholar 

  47. Macgown CK, Kellenberger CJ, Detsky JS, Roman K, Yoo SJ. Real-time fourier velocity encoding: an in vivo evaluation. J Magn Reson Imaging. 2005;21:297–304.

    Article  Google Scholar 

  48. O'Brien KR, Myerson SG, Cowan BR, Young AA, Robson MD. Phase contrast ultrashort TE: a more reliable technique for measurement of high-velocity turbulent stenotic jets. Magn Reson Med. 2009;62:626–36.

    Article  PubMed  Google Scholar 

  49. Krombach GA, Kuhl H, Bucker A. Cine MR imaging of heart valve dysfunction with segmented true fast imaging with steady state free precession. J Magn Reson Imaging. 2004;19:59–67.

    Article  PubMed  Google Scholar 

  50. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349(11):1027–35.

    Article  CAS  PubMed  Google Scholar 

  51. Kitamura M, Shimizu M, Ino H. Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collages. Clin Cardiol. 2001;24:325–9.

    Article  CAS  PubMed  Google Scholar 

  52. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011;258(1):128–33.

    Article  PubMed  Google Scholar 

  53. Amano Y, Takayama M, Takaham K, Kumazaki T. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. J Magn Reson Imaging. 2004;20:595–600.

    Article  PubMed  Google Scholar 

  54. Moon JC, McKenna WJ, McCrohon JA. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561–7.

    Article  PubMed  Google Scholar 

  55. Choudhury L, Mahrholdt H, Wagner A. Myocardial scarring in minimally symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:2156–64.

    Article  PubMed  Google Scholar 

  56. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy, A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58(25):e212–60.

    Article  CAS  PubMed  Google Scholar 

  57. Rubinshtein R, Glockner JF, Ommen SR. Characteristics and clinical significance of late gadolinium enhancement by contrast enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3:51–8.

    Article  PubMed  Google Scholar 

  58. Green JJ, Berger JS, Kramer CM, Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2012;5(4):370–7.

    Article  PubMed  Google Scholar 

  59. Rudolph A, Abdel-Aty H, Bohl S. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009;53:284–91.

    Article  PubMed  Google Scholar 

  60. Azevedo CF, Nigri M, Higuchi ML. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic stenosis. J Am Coll Cardiol. 2010;56:278–87.

    Article  PubMed  Google Scholar 

  61. Petersen SE, Selvanayagam JB, Francis JM. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2005;7:551–8.

    Article  PubMed  Google Scholar 

  62. Caruthers SD, Lin SJ, Brown P. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation. 2003;108:2236–43.

    Article  PubMed  Google Scholar 

  63. Oliver JM, Gonzalez A, Gallego P, Sanchez-recalde A, Benito F, Mesa JM. Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation. J Am Coll Cardiol. 2001;38(3):35–42.

    Article  Google Scholar 

  64. Austin BA, Tang WH, Rodriguez ER. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. J Am Coll Cardiol Img. 2009;2:1369–77.

    Article  Google Scholar 

  65. Maceira AM, Joshi J, Prasad SK. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–93.

    Article  PubMed  Google Scholar 

  66. Smedema JP, Snoep G, van Kroonenburgh MP. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683–90.

    Article  PubMed  Google Scholar 

  67. Puvaneswary M, Joshua F, Ratnarajah S. Idiopathic hypereosinophilic syndrome: magnetic resonance imaging findings in endomyocardial fibrosis. Australas Radiol. 2001;45:524–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Winthrop University Hospital, 259 1st Street, Mineola, NY, 11501, USA

    Jonathan Kahan MD

  2. Department of Cardiology, Winthrop University Hospital, 120 Mineola Boulevard, Suite 500, Mineola, NY, 11501, USA

    Juan Gaztanaga MD

  3. Division of Cardiology, Department of Medicine, Montefiore – Einstein Center for Heart and Vascular Care, Albert Einstein College of Medicine, 111 East 210th Street, Silver Zone, Bronx, NY, 10467-2400, USA

    Mario Jorge Garcia MD

Authors
  1. Jonathan Kahan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Gaztanaga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mario Jorge Garcia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Jorge Garcia MD .

Editor information

Editors and Affiliations

  1. Winthrop University Hospital, Mineola, New York, USA

    Srihari S. Naidu

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Kahan, J., Gaztanaga, J., Garcia, M.J. (2015). Cardiac MRI in Diagnosis and Management. In: Naidu, S. (eds) Hypertrophic Cardiomyopathy. Springer, London. https://doi.org/10.1007/978-1-4471-4956-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4956-9_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4955-2

  • Online ISBN: 978-1-4471-4956-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation